The world's top 10 generic drug giants, who is carrying the load, and who is "running naked"?

At a time when innovative drugs are constantly being sought after by the market, generic drugs are under severe pressure due to prici.

Recently, FiercePharma released the 2021 global generic drug giant TOP10 li.

The two giants have negative growth in performance

What is the reason?

It is worth noting that although Teva and Novartis' Sandoz are ranked first or second in the world, they are also the only two companies in the TOP10 list whose sales performance of generic drugs has declined, with a negative growth of about

Teva is Israel's leading generic drug manufacturer and is recognized as the largest generic drug manufacturer in the wor.

However, the plan could not keep up with the chang.

In addition, the expiration of Teva’s patents on the original drug Copaxone and Proair and the failure of the “successor” clinical trials are the main reasons for the decline in Teva’s performance in recent yea.

Novartis' Sandoz was founded in 1886 and was launched in 2003 as Novartis' generics divisi.

Correspondingly, Novartis regards promoting the launch of innovative drugs as the goal of Novartis' performance grow.

However, in the difficult situation, Sandoz is not discouraged, and constantly seeks to expand its product ran.

8 performance growth

2 increased by more than 10%

Where there is decline, there is grow.

Aspen was established in South Africa in 1997 and is one of the first generic drug factories in South Afri.

       Aspen currently operates 23 manufacturing plants in 10 countries on six continents, with more operations in Europe (36% of its revenue) than in Africa and the Middle East (25.

       Aspen generated ZAR 38 billion ($2 billion) in 2021, up 12% from ZAR 36 billion in 202 In 2021, the sales growth of generic drugs in the TOP10 list of global generic drug companies reached double digi.

       However, Aspen is also undergoing structural optimization and business restructuri.

       .

       Among them, generic drugs make up the majority of .

       At the same time, .

Reddy's Laboratories is still expanding its generic produc.

In October 2021, it won FDA approval for a generic version of its multiple myeloma blockbuster drug Revlimid, and reached an agreement with B.

Launch its generic version "on a confidential date" after Mar.

       On the brand side of the pharmaceutical business, .

Reddy's Laboratories also made headlines when it signed a sales and distribution deal with Novartis India in February this year to focus on certain established dru.

Under this collaboration, Novartis will join .

Reddy's Laboratories' sales and distribution force in India to manufacture and develop technologi.

       The future of Chinese generic pharmaceutical companies

       Will it be on the list?

       In the list of generic drug giants, no matter whether it is a company that is under severe pressure and has fallen sharply, or is still striding forward in adversity, or maintains stability, there is no Chinese generic drug compa.

There are 4 companies in Ind.

The companies listed are Sun Pharmaceutical, Sun, Aurobindo, .

Reddy'sLab, and Cip.

So China, which is also a big country of generic drugs, will have the top ten generic drug companies in the world in the future?

       Industry insiders once analyzed and pointed out: "Even now, the concentration of Chinese generic drug companies is still too low, and there is no integrat.

Chinese pharmaceutical companies have not undergone major mergers and acquisitions, and global generic drug companies are all through acquisitio.

Complet.

" For example, Viatris, the third winner of the 2021 global generic drug giant TOP10 list, was formed by the merger of Mylan and Pfizer's patent expired brand and generic drug business unit - Upjohn in 201 One of the world's largest generic drug compani.

       In addition, China is still undergoing medical reform, consistency evaluation, centralized procurement, medical insurance negotiation, e.

are all driving down drug prices, and drugs are gradually moving towards a low-margin e.

Therefore, various pharmaceutical companies are constantly innovating, transforming, and innovating research and developme.

       The consequences of this change in China will make pharmaceutical companies more polariz.

Excellent innovative drug companies stand out, and pharmaceutical giants that have successfully transformed generic drugs to a higher level; and when many companies are thinking about transforming innovative drug companies, the generic drug companies that want to be China's Teva do not know whe.

? If there is, I hope that it can focus more on Southeast Asia, Russia, Latin America and countries along the Belt and Road while developing mature markets such as Europe, America and Jap.

Not only will China's innovative medicine be nationalized, but generic drugs will also be internationalized, and simultaneously develop China's pharmaceutical giant into a pharmaceutical pow.